These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The electronic cigarette: a wolf in sheep's clothing. Neuberger M Wien Klin Wochenschr; 2015 May; 127(9-10):385-7. PubMed ID: 26230008 [TBL] [Abstract][Full Text] [Related]
6. Policy and health implications of using the U.S. Food and Drug Administration product design approach in reducing tobacco product risk. Givel M Curr Drug Abuse Rev; 2008 Jun; 1(2):135-41. PubMed ID: 19630712 [TBL] [Abstract][Full Text] [Related]
7. Flavoured tobacco products in the USA: synthesis of recent multidiscipline studies with implications for advancing tobacco regulatory science. Stanton CA; Villanti AC; Watson C; Delnevo CD Tob Control; 2016 Nov; 25(Suppl 2):ii1-ii3. PubMed ID: 27856996 [No Abstract] [Full Text] [Related]
8. The Ethics of Tobacco Harm Reduction: An Analysis of E-Cigarette Availability From the Perspectives of Utilitarianism, Bioethics, and Public Health Ethics. Thomas R; Parker LS; Shiffman S Nicotine Tob Res; 2021 Jan; 23(1):3-8. PubMed ID: 33002156 [TBL] [Abstract][Full Text] [Related]
10. A Risk Assessment Matrix for Public Health Principles: The Case for E-Cigarettes. Saitta D; Chowdhury A; Ferro GA; Nalis FG; Polosa R Int J Environ Res Public Health; 2017 Mar; 14(4):. PubMed ID: 28362360 [TBL] [Abstract][Full Text] [Related]
11. Electronic nicotine delivery systems: executive summary of a policy position paper from the American College of Physicians. Crowley RA; Ann Intern Med; 2015 Apr; 162(8):583-4. PubMed ID: 25894027 [TBL] [Abstract][Full Text] [Related]
12. The Dangerous Flavors of E-Cigarettes. Drazen JM; Morrissey S; Campion EW N Engl J Med; 2019 Feb; 380(7):679-680. PubMed ID: 30699053 [No Abstract] [Full Text] [Related]
13. The threat of menthol cigarettes to U.S. public health. Benowitz NL; Samet JM N Engl J Med; 2011 Jun; 364(23):2179-81. PubMed ID: 21542737 [No Abstract] [Full Text] [Related]
14. No sisyphean task: how the FDA can regulate electronic cigarettes. Paradise J Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824 [TBL] [Abstract][Full Text] [Related]
15. Adolescent use of electronic nicotine delivery systems. Vincent D; Potts J; Durbin J; Moore JM; Eley S Nurse Pract; 2018 Mar; 43(3):17-21. PubMed ID: 29438183 [TBL] [Abstract][Full Text] [Related]
16. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction. Kozlowski LT Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913 [TBL] [Abstract][Full Text] [Related]
17. E-Cigarettes and the Harm-Reduction Continuum. Fairchild AL; Lee JS; Bayer R; Curran J N Engl J Med; 2018 Jan; 378(3):216-219. PubMed ID: 29342380 [No Abstract] [Full Text] [Related]
18. Electronic cigarettes and alternative nicotine products. Hanson K NCSL Legisbrief; 2014 Jul; 22(26):1-2. PubMed ID: 25514811 [TBL] [Abstract][Full Text] [Related]
19. The importance of product definitions in US e-cigarette laws and regulations. Lempert LK; Grana R; Glantz SA Tob Control; 2016 Apr; 25(e1):e44-51. PubMed ID: 25512432 [TBL] [Abstract][Full Text] [Related]
20. A licence to vape: Is it time to trial of a nicotine licensing scheme to allow Australian adults controlled access to electronic cigarettes devices and refill solutions containing nicotine? Gartner C; Hall W Int J Drug Policy; 2015 Jun; 26(6):548-53. PubMed ID: 25817484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]